Suite 506, Level 5 50 Clarence Street, Sydney NSW 2000, Australia hello@breathelifesciences.com +61 2 9078 8180 BLS Pharmaceuticals Ltd | ASX:BLS | www.blspharma.com 1 7 October 2026 AGM & Director Nominations In accordance with ASX Listing Rule 3.13.1 BLS Pharmaceuticals Limited (ASX:BLS)...
AGM Date and Director Nominations
Filed with ASX · · 2 pages · English
Release
BLS Pharmaceuticals Limited on 6ix
Earlier from BLS Pharmaceuticals
- Application for quotation of securities - BLS
- Initial Director's Interest Notice
- Angus Walker Appointed Alternate Director to Edward Myer
- S&P DJI Announces September 2026 Quarterly Rebalance
- Appendix 4G Corporate Governance Statement
Later from BLS Pharmaceuticals
- Becoming a substantial holder
- Ceasing to be a substantial holder
- Quarterly Activities/Appendix 4C Cash Flow Report
- BLS Quarterly Activities Report September 2026 Revised
- Q1 FY2027 Quarterly Activities Update
Follow BLS Pharmaceuticals into a list and get an email when it puts out news.
Follow BLS Pharmaceuticals